Emerging incretin and multi agonist based treatments the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio kidney liver metabolic diseases and beyond Metabolism Clinical and Experimental Cagrilintide Peptide Therapy: A New Era in Appetite Control and Weight Revolution Health & Wellness Frontiers The potential of glucagon like peptide 1 receptor agonists in heart failure Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes New England Journal of Medicine A Real World Study of the Effectiveness and Safety of Semaglutide for Weight Loss Cureus